{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:47:48Z","timestamp":1782730068769,"version":"3.54.5"},"reference-count":33,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MHLW Research Program on Rare and Intractable Disease","award":["JPMH26FC1010"],"award-info":[{"award-number":["JPMH26FC1010"]}]},{"name":"JSPS KAKENHI","award":["25K11075"],"award-info":[{"award-number":["25K11075"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Enzyme replacement therapy (ERT) for central nervous system symptoms and newborn screening (NBS) is available in Japan for patients with mucopolysaccharidosis type II (MPS II). Of 12 suspected cases identified through the NBS program, 3 patients were diagnosed with neuronopathic MPS II (2 directly from the screened cohort and 1 affected sibling). We reviewed the clinical courses of these patients, who were treated with intracerebroventricular (ICV) ERT using idursulfase beta (Hunterase\u00ae) followed by umbilical cord blood transplantation (CBT). Heparan sulfate (HS) in the cerebrospinal fluid (CSF) was longitudinally measured as a therapeutic biomarker, and developmental age was evaluated. All patients achieved successful engraftment with no severe complications, except for one patient with sinusoidal obstruction syndrome. The CSF HS concentration showed a temporary increase during the ERT discontinuation period, which can be attributed to CBT, and a subsequent reduction after the resumption of ICV-ERT. The patients exhibited age-appropriate development. The pattern of change in HS indicates the importance of continuing ICV-ERT even after hematopoietic stem cell transplantation. The study results demonstrate that the combination of ICV-ERT and CBT may yield promising outcomes in patients with neuronopathic MPS II, underscoring the importance of early intervention through NBS.<\/jats:p>","DOI":"10.3390\/ijns12030047","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:20Z","timestamp":1782722720000},"page":"47","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined Intracerebroventricular Enzyme Replacement and Cord Blood Transplantation in Patients with Mucopolysaccharidosis Type II Diagnosed Through Newborn Screening"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6760-6766","authenticated-orcid":false,"given":"Yuki","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-0968","authenticated-orcid":false,"given":"Shinsuke","family":"Hirabayashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Miura","sequence":"additional","affiliation":[{"name":"Hokkaido Pharmaceutical Association Public Health Examination Center, Hiragishi 1-jo, 8-chome, Toyohira-Ku, Sapporo 062-0931, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Nakakubo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutaro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1700-5337","authenticated-orcid":false,"given":"Yukayo","family":"Terashita","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-2348","authenticated-orcid":false,"given":"Atsushi","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torayuki","family":"Okuyama","sequence":"additional","affiliation":[{"name":"Department of Genomic Medicine, Saitama Medical University Hospital, Morohongo 38, Moroyamamachi, Iruma-gun, Saitama 350-0451, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8224-7012","authenticated-orcid":false,"given":"Kiyoshi","family":"Egawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University Hospital, North 14, West 5, Kita-Ku, Sapporo 060-8648, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): A clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"107557","DOI":"10.1016\/j.ymgme.2023.107557","article-title":"Newborn screening for mucopolysaccharidosis type II: Lessons learned","volume":"140","author":"Burton","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"D\u2019Avanzo, F., Rigon, L., Zanetti, A., and Tomanin, R. (2020). Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041258"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ymgme.2018.07.001","article-title":"Critical review of current MPS guidelines and management","volume":"126","author":"Stapleton","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_6","first-page":"100630","article-title":"Natural history of cognitive development in neuronopathic mucopolysaccharidosis type II (Hunter syndrome): Contribution of genotype to cognitive developmental course","volume":"24","author":"Seo","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.36469\/jheor.2022.36540","article-title":"Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review","volume":"9","author":"Yee","year":"2022","journal-title":"J. Health Econ. Outcomes Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","article-title":"Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: A nationwide survey in Japan","volume":"107","author":"Tanaka","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2009.05.006","article-title":"Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation","volume":"98","author":"Araya","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbmt.2017.06.020","article-title":"Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II","volume":"23","author":"Kubaski","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13052-025-01919-7","article-title":"Allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis patients: A single-center experience and assessment of quality of life","volume":"51","author":"Zhang","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/gim.2015.36","article-title":"A phase I\/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II","volume":"18","author":"Muenzer","year":"2016","journal-title":"Genet. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.omtm.2021.02.018","article-title":"Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II","volume":"21","author":"Seo","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A Phase 2\/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Giugliani, R., Martins, A.M., Okuyama, T., Eto, Y., Sakai, N., Nakamura, K., Morimoto, H., Minami, K., Yamamoto, T., and Yamaoka, M. (2021). Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202109.0192.v1"},{"key":"ref_17","first-page":"101003","article-title":"Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan","volume":"37","author":"Hattori","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cca.2012.01.012","article-title":"An improved method for glycosaminoglycan analysis by LC-MS\/MS of urine samples collected on filter paper","volume":"413","author":"Lavoie","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"ref_20","first-page":"597","article-title":"Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: Toward mutation mapping of the iduronate-2-sulfatase gene","volume":"56","author":"Jonsson","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_21","first-page":"101254","article-title":"Case report of neuronopathic mucopolysaccharidosis type II: Early intracerebroventricular enzyme replacement therapy and hematopoietic cell transplantation with developmental outcomes up to 5 years of age","volume":"45","author":"Ikari","year":"2025","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Fukatsu, T., Morio, H., Furihata, T., and Sonoda, H. (2023). Transferrin receptor-targeting property of pabinafusp alfa facilitates its uptake by various types of human brain-derived cells in vitro. Front. Drug Deliv., 3.","DOI":"10.3389\/fddev.2023.1082672"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/petr.12672","article-title":"Hematopoietic stem cell transplantation for inborn errors of metabolism: A report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the Japan Society for Hematopoietic Cell Transplantation","volume":"20","author":"Kato","year":"2016","journal-title":"Pediatr. Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(04)16628-2","article-title":"Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children","volume":"364","author":"Jacobsohn","year":"2004","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2008-03-140830","article-title":"Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: Influence of cellular composition of the graft on transplantation outcomes","volume":"112","author":"Prasad","year":"2008","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","article-title":"Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation","volume":"24","author":"Nishida","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e31331","DOI":"10.1002\/pbc.31331","article-title":"Early defibrotide therapy and risk factors for post-transplant veno-occlusive disease\/sinusoidal obstruction syndrome in childhood","volume":"71","author":"Goto","year":"2024","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.2009.07974.x","article-title":"Cord blood and bone marrow transplantation in inherited metabolic diseases: Scientific basis, current status and future directions","volume":"148","author":"Prasad","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"109911","DOI":"10.1016\/j.ymgme.2026.109911","article-title":"Cerebrospinal fluid heparan sulfate as a biomarker for neuronopathic mucopolysaccharidoses: Rationale and regulatory challenges","volume":"148","author":"Muenzer","year":"2026","journal-title":"Mol. Genet. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ymthe.2024.01.034","article-title":"An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II","volume":"32","author":"Das","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","article-title":"Epidemiology of mucopolysaccharidoses","volume":"121","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ayodele, O., Fertek, D., Evuarherhe, O., Siffel, C., Audi, J., Yee, K.S., and Burton, B.K. (2024). A Systematic Literature Review on the Global Status of Newborn Screening for Mucopolysaccharidosis II. Int. J. Neonatal Screen., 10.","DOI":"10.3390\/ijns10040071"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102596","DOI":"10.1016\/j.gim.2026.102596","article-title":"Nationwide Newborn Screening for Mucopolysaccharidoses in Taiwan: Impact, Early Diagnosis, and Clinical Advances over the Past Decade","volume":"28","author":"Chuang","year":"2026","journal-title":"Genet. Med."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/12\/3\/47\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:22:38Z","timestamp":1782728558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/12\/3\/47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijns12030047"],"URL":"https:\/\/doi.org\/10.3390\/ijns12030047","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}